Literature DB >> 21699811

A Crohn's disease patient who does not respond to infliximab: what is next?

Nitsan Maharshak1, Scott E Plevy.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21699811     DOI： 10.1016/j.cgh.2011.05.027

Source DB:  PubMed          Journal:  Clin Gastroenterol Hepatol        ISSN： 1542-3565            Impact factor:   11.382


× No keyword cloud information.
  2 in total

1.  Optimizing infliximab therapy for inflammatory bowel disease- the tools are getting sharper.

Authors:  Marie-France Dubeau; Subrata Ghosh
Journal:  Gastroenterol Hepatol (N Y)       Date:  2012-02

2.  Genetic Polymorphisms of IL-17F and TRAF3IP2 Could Be Predictive Factors of the Long-Term Effect of Infliximab against Crohn's Disease.

Authors:  Shigetoshi Urabe; Hajime Isomoto; Tetsuya Ishida; Kazumi Maeda; Tatsuo Inamine; Shinji Kondo; Norihide Higuchi; Kayoko Sato; Ryohei Uehara; Hiroyuki Yajima; Haruhisa Machida; Chun Chuan Chen; Yasuhiro Fukuda; Fuminao Takeshima; Kazuhiko Nakao; Kazuhiro Tsukamoto
Journal:  Biomed Res Int       Date:  2015-10-19       Impact factor: 3.411
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.